Clifford Chance advised dsm-firmenich on the deal. dsm-firmenich, innovators in nutrition, health, and beauty, completed the successful launch of a €750 million bond with an 11-year...
You must be a Standard 1 Year member to access this content.
Baker McKenzie and Plesner advised Novonesis on the deal. Clifford Chance advised dsm-firmenich. Novonesis has completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance...
You must be a Standard 1 Year member to access this content.
On the deal, Cravath, Swaine & Moore, Bredin Prat and Bär & Karrer acted as legal advisors to DSM-Firmenich. DSM-Firmenich, a leading specialist in innovation in...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised dsm-firmenich on the deal. KD Pharma Group SA, a contract development and manufacturing organization (CDMO) active in pharmaceutical and nutritional lipids, has...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised dsm-firmenich on the sale. dsm-firmenich, innovators in nutrition, health and beauty, announced an agreement to sell its yeast extract business (Yeast Extracts)...
You must be a Standard 1 Year member to access this content.
